Top

Published in:

01-03-2008

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

Author: Alexander I. Tröster

Published in: Neuropsychology Review | Issue 1/2008

Abstract

Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB) are neurodegenerative conditions sharing a disorder of α-synuclein metabolism. Temporal differences in the emergence of symptoms and clinical features warrant the continued clinical distinction between DLB and PDD. While DLB and PDD groups’ neuropsychological profiles often differ from those in Alzheimer’s disease (AD), the diagnostic sensitivity, specificity, and predictive values of these profiles remain largely unknown. PDD and DLB neuropsychological profiles share sufficient similarity to resist accurate and reliable differentiation. Although heterogeneous cognitive changes (predominantly in memory and executive function) may manifest earlier and more frequently than previously appreciated in Parkinson’s disease (PD), and executive deficits may be harbingers of dementia, the enthusiasm to uncritically extend the concept of mild cognitive impairment (MCI) to PD should be tempered. Instead, future research might strive to identify the precise neuropsychological characteristics of the prodromal stages of PD, PDD, and DLB which, in conjunction with other potential biomarkers, facilitate early and accurate diagnosis, and the definition of neuroprotective, neurorestorative, and symptomatic treatment endpoints.

Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., & Kragh-Sorensen, P. (2003a). Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology, 60(3), 387–392.PubMed

Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh-Sorensen, P. (2001). Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology, 56(6), 730–736.PubMed

Aarsland, D., Litvan, I., Salmon, D., Galasko, D., Wentzel-Larsen, T., & Larsen, J. P. (2003b). Performance on the Dementia Rating Scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 1215–1220.PubMed

Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20(10), 1255–1263.PubMed

Ala, T. A., Hughes, L. F., Kyrouac, G. A., Ghobrial, M. W., & Elble, R. J. (2001). Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70(4), 483–488.PubMed

Albert, M. S., & Blacker, D. (2006). Mild cognitive impairment and dementia. Annual Review Clinical Psychology, 2, 379–388.

Alves, G., Larsen, J. P., Emre, M., Wentzel-Larsen, T., & Aarsland, D. (2006). Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Movement Disorders, 21(8), 1123–1130.PubMed

Athey, R. J., Porter, R. W., & Walker, R. W. (2005). Cognitive assessment of a representative community population with Parkinson’s disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). Age and Ageing, 34(3), 268–273.PubMed

Ballard, C. G., Aarsland, D., McKeith, I., O’Brien, J., Gray, A., Cormack, F., et al. (2002). Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology, 59(11), 1714–1720.PubMed

Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O’Brien, J., McKeith, I., et al. (2006). Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology, 67(11), 1931–1934.PubMed

Biggins, C. A., Boyd, J. L., Harrop, F. M., Madeley, P., Mindham, R. H., Randall, J. I., et al. (1992). A controlled, longitudinal study of dementia in Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 55(7), 566–571.PubMed

Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., et al. (2006). Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia. Journal of Neurology, 253(2), 242–247.PubMed

Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., et al. (2003). Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Archives of Neurology, 60(12), 1745–1748.PubMed

Bohnen, N. I., Kuwabara, H., Constantine, G. M., Mathis, C. A., & Moore, R. Y. (2007). Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson’s disease. Neuroscience Letters, 424(3), 185–189.PubMed

Boller, F., Marcie, P., Starkstein, S., & Traykov, L. (1998). Memory and depression in Parkinson’s disease. European Journal of Neurology, 5, 291–295.PubMed

Braak, H., Bohl, J. R., Muller, C. M., Rub, U., de Vos, R. A., & Del Tredici, K. (2006a). Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Movement Disorders, 21(12), 2042–2051.PubMed

Braak, H., Rub, U., & Del Tredici, K. (2006b). Cognitive decline correlates with neuropathological stage in Parkinson’s disease. Journal of Neurological Sciences, 248(1–2), 255–258.

Braak, H., Rub, U., Jansen Steur, E. N., Del Tredici, K., & de Vos, R. A. (2005). Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology, 64(8), 1404–1410.PubMed

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24(2), 197–211.PubMed

Bradshaw, J. M., Saling, M., Anderson, V., Hopwood, M., & Brodtmann, A. (2006). Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls. Journal of Neurology, Neurosurgery and Psychiatry, 77(10), 1129–1135.

Cahn-Weiner, D. A., Williams, K., Grace, J., Tremont, G., Westervelt, H., & Stern, R. A. (2003). Discrimination of dementia with lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cognitive and Behavioral Neurology, 16(2), 85–92.PubMed

Calderon, J., Perry, R. J., Erzinclioglu, S. W., Berrios, G. E., Dening, T. R., & Hodges, J. R. (2001). Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70(2), 157–164.PubMed

Caviness, J. N., Driver-Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., et al. (2007). Defining mild cognitive impairment in Parkinson’s disease. Movement Disorders, 22(9), 1272–1277.PubMed

Collerton, D., Burn, D., McKeith, I., & O’Brien, J. (2003). Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dementia and Geriatric Cognitive Disorders, 16(4), 229–237.PubMed

Connor, D. J., Salmon, D. P., Sandy, T. J., Galasko, D., Hansen, L. A., & Thal, L. J. (1998). Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Archives of Neurology, 55(7), 994–1000.PubMed

Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson’s disease. Neuroscience and Biobehavioral Reviews, 30(1), 1–23.PubMed

Cormack, F., Aarsland, D., Ballard, C., & Tovee, M. J. (2004a). Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. International Journal of Geriatric Psychiatry, 19(4), 371–377.PubMed

Cormack, F., Gray, A., Ballard, C., & Tovee, M. J. (2004b). A failure of ‘pop-out’ in visual search tasks in dementia with Lewy Bodies as compared to Alzheimer’s and Parkinson’s disease. International Journal of Geriatric Psychiatry, 19(8), 763–772.PubMed

de Lau, L. M., Schipper, C. M., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2005). Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Archives of Neurology, 62(8), 1265–1269.PubMed

Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test—2nd Edition—Adult Version. San Antonio: The Psychological Corporation.

Dorsey, E. R., Holloway, R. G., & Ravina, B. M. (2006). Biomarkers in Parkinson’s disease. Expert Rev Neurother, 6(6), 823–831.PubMed

Doubleday, E. K., Snowden, J. S., Varma, A. R., & Neary, D. (2002). Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 72(5), 602–607.PubMed

Downes, J. J., Priestley, N. M., Doran, M., Ferran, J., Ghadiali, E., & Cooper, P. (1998). Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson’s disease. Behavioural Neurology, 11(3), 173–183.PubMed

Dubois, B. (2007). Is PD-MCI a useful concept? Movement Disorders, 22(9), 1215–1216.PubMed

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.PubMed

Ferman, T. J., Smith, G. E., Boeve, B. F., Graff-Radford, N. R., Lucas, J. A., Knopman, D. S., et al. (2006). Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. The Clinical Neuropsychologist, 20(4), 623–636.PubMed

Fernandez, H. H., Crucian, G. P., Okun, M. S., Price, C. C., & Bowers, D. (2005). Mild cognitive impairment in Parkinson’s disease: the challenge and the promise. Neuropsychiatric Disease and Treatment, 1, 37–50.PubMed

Filoteo, J. V., Rilling, L. M., Cole, B., Williams, B. J., Davis, J. D., & Roberts, J. W. (1997). Variable memory profiles in Parkinson’s disease. Journal of Clinical and Experimental Neuropsychology, 19(6), 878–888.PubMed

Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., et al. (2007). Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology, 68(4), 288–291.PubMed

Folstein, M. F., Folstein, S. E., & Fanjiang, G. (2001). Mini-Mental State Examination clinical guide. Lutz, FL, USA: Psychological Assessment Resources.

Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2004). The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain, 127(Pt 3), 550–560.PubMed

Freedman, M., Rivoira, P., Butters, N., Sax, D. S., & Feldman, R. G. (1984). Retrograde amnesia in Parkinson’s disease. Canadian Journal of Neurological Sciences, 11(2), 297–301.PubMed

Galvin, J. E. (2006). Cognitive change in Parkinson disease. Alzheimer Disease and Associated Disorders, 20(4), 302–310.PubMed

Galvin, J. E., Pollack, J., & Morris, J. C. (2006). Clinical phenotype of Parkinson disease dementia. Neurology, 67(9), 1605–1611.PubMed

Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56(1), 33–39.PubMed

Gilbert, P. E., Barr, P. J., & Murphy, C. (2004). Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer’s disease and the Lewy body variant of Alzheimer’s disease. Journal of the International Neuropsychological Society, 10(6), 835–842.PubMed

Glatt, S. L., Hubble, J. P., Lyons, K., Paolo, A., Tröster, A. I., Hassanein, R. E., et al. (1996). Risk factors for dementia in Parkinson’s disease: effect of education. Neuroepidemiology, 15(1), 20–25.PubMed

Gnanalingham, K. K., Byrne, E. J., Thornton, A., Sambrook, M. A., & Bannister, P. (1997). Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. Journal of Neurology, Neurosurgery, and Psychiatry, 62(3), 243–252.PubMedCrossRef

Goetz, C. G. (1992). The historical background of behavioral studies in Parkinson’s disease. In S. J. Huber, & J. L. Cummings (Eds.) Parkinson’s Disease: Neurobehavioral Aspects (pp. 3–9). New York: Oxford University Press.

Halliday, G. M., Del Tredici, K., & Braak, H. (2006). Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease. Journal of Neural Transmission. Supplementum, 70, 99–103.PubMed

Hamilton, J. M., Salmon, D. P., Galasko, D., Delis, D. C., Hansen, L. A., Masliah, E., et al. (2004). A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer’s disease. Journal of the International Neuropsychological Society, 10(5), 689–697.PubMed

Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., et al. (1990). The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology, 40(1), 1–8.PubMed

Harding, A. J., Broe, G. A., & Halliday, G. M. (2002). Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain, 125(Pt 2), 391–403.PubMed

Heaton, R. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin Card Sorting Test Manual. Odessa: Psychological Assessment Resources.

Heiss, C., Kalbe, E., & Kessler, J. (2001). Quantitative und qualitative Analysen von verbalen Flüssigkeitsaufgaben bei Parkinsonpatienten. Zeitschrift für Neuropsychologie, 12(3), 188–199.

Hely, M. A., Morris, J. G., Reid, W. G., & Trafficante, R. (2005). Sydney Multicenter Study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Movement Disorders, 20(2), 190–199.PubMed

Hobson, P., Gallacher, J., & Meara, J. (2005). Cross-sectional survey of Parkinson’s disease and parkinsonism in a rural area of the United Kingdom. Movement Disorders, 20(8), 995–998.PubMed

Hodges, J. R., Salmon, D. P., & Butters, N. (1991). The nature of the naming deficit in Alzheimer’s and Huntington’s disease. Brain, 114(Pt 4), 1547–1558.PubMed

Holdorff, B. (2002). Friedrich Heinrich Lewy (1885–1950) and his work. Journal of the History of the Neurosciences, 11(1), 19–28.PubMed

Huber, S. J., Shuttleworth, E. C., & Paulson, G. W. (1986). Dementia in Parkinson’s disease. Archives of Neurology, 43(10), 987–990.PubMed

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry, 55(3), 181–184.

Hughes, T. A., Ross, H. F., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H., et al. (2000). A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology, 54(8), 1596–1602.PubMed

Jacobs, D. M., Marder, K., Cote, L. J., Sano, M., Stern, Y., & Mayeux, R. (1995). Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology, 45(9), 1691–1696.PubMed

Janvin, C. C., Aarsland, D., & Larsen, J. P. (2005). Cognitive predictors of dementia in Parkinson’s disease: a community-based, 4-year longitudinal study. Journal of Geriatric Psychiatry and Neurology, 18(3), 149–154.PubMed

Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006a). Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Movement Disorders, 21(9), 1343–1349.PubMed

Janvin, C. C., Larsen, J. P., Salmon, D. P., Galasko, D., Hugdahl, K., & Aarsland, D. (2006b). Cognitive profiles of individual patients with Parkinson’s disease and dementia: comparison with dementia with lewy bodies and Alzheimer’s disease. Movement Disorders, 21(3), 337–342.PubMed

Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., et al. (2006). Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Archives of Neurology, 63(5), 674–681.PubMed

Kaufer, D. I. (2004). Pharmacologic treatment expectations in the management of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 17(Suppl 1), 32–39.PubMed

Kaufer, D. L., & Tröster, A. I. (2008). Neuropsychology of dementia with Lewy bodies. In G. Goldenberg, & B. L. Miller (Eds.) Handbook of Clinical Neurology: Neuropsychology and Behavioral Neurology (vol. 88, 3rd Ed.). Amsterdam: Elsevier.

Kosaka, K. (1990). Diffuse Lewy body disease in Japan. Journal of Neurology, 237(3), 197–204.PubMed

Kosaka, K., Matsushita, M., Oyanagi, S., & Mehraein, P. (1980). [A cliniconeurophathological study of the “Lewy body disease”]. Seishin Shinkeigaku Zasshi, 82(5), 292–311.PubMed

Kraybill, M. L., Larson, E. B., Tsuang, D. W., Teri, L., McCormick, W. C., Bowen, J. D., et al. (2005). Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology, 64(12), 2069–2073.PubMed

Lambon Ralph, M. A., Powell, J., Howard, D., Whitworth, A. B., Garrard, P., & Hodges, J. R. (2001). Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer’s type: a comparative neuropsychological study and literature review. Journal of Neurology, Neurosurgery, and Psychiatry, 70(2), 149–156.PubMed

Lang, C. J., Leuschner, T., Ulrich, K., Stossel, C., Heckmann, J. G., & Hummel, T. (2006). Taste in dementing diseases and parkinsonism. Journal of the Neurological Sciences, 248(1–2), 177–184.PubMed

Leplow, B., Dierks, C., Herrmann, P., Pieper, N., Annecke, R., & Ulm, G. (1997). Remote memory in Parkinson’s disease and senile dementia. Neuropsychologia, 35(4), 547–557.PubMed

Leroi, I., Collins, D., & Marsh, L. (2006). Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson’s disease: a review. Journal of Neurological Sciences, 248(1–2), 104–114.

Lewy, F. H. (1912). Paralysis agitans I. Pathologische Anatomie. In M. Lewandowsky (Ed.) Handbuch der Neurologie, Band 3 (pp. 920–933). Berlin: Springer.

Lewy, F. H. (1923). Die Lehre vom Tonus und der Bewegung. Zugleich Systmatische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis Agitans. Berlin: Julius Springer.

Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., et al. (2007). DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology, 68(11), 812–819.PubMed

Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C., et al. (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56(5), 643–649.PubMed

Louis, E. D., & Bennett, D. A. (2007). Mild Parkinsonian signs: An overview of an emerging concept. Movement Disorders, 22(12), 1681–1688.PubMed

Louis, E. D., Schupf, N., Manly, J., Marder, K., Tang, M. X., & Mayeux, R. (2005). Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology, 64(7), 1157–1161.PubMed

Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M. J., Michelet, D., & Boller, F. (1998). Neuropsychological prediction of dementia in Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 64(2), 178–183.PubMed

Marder, K., Tang, M. X., Cote, L., Stern, Y., & Mayeux, R. (1995). The frequency and associated risk factors for dementia in patients with Parkinson’s disease. Archives of Neurology, 52(7), 695–701.PubMed

Martin, A., & Fedio, P. (1983). Word production and comprehension in Alzheimer’s disease: the breakdown of semantic knowledge. Brain and Language, 19(1), 124–141.PubMed

Mattis, S. (2001). Dementia Rating Scale-2. Lutz, FL, USA: Psychological Assessment Resources.

Mayeux, R., Chen, J., Mirabello, E., Marder, K., Bell, K., Dooneief, G., et al. (1990). An estimate of the incidence of dementia in idiopathic Parkinson’s disease. Neurology, 40(10), 1513–1517.PubMed

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12), 1863–1872.PubMed

Metzler-Baddeley, C. (2007). A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer’s disease and Parkinson’s disease with dementia. Cortex, 43(5), 583–600.PubMed

Michell, A. W., Lewis, S. J., Foltynie, T., & Barker, R. A. (2004). Biomarkers and Parkinson’s disease. Brain, 127(Pt 8), 1693–1705.PubMed

Miech, R. A., Breitner, J. C., Zandi, P. P., Khachaturian, A. S., Anthony, J. C., & Mayer, L. (2002). Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology, 58(2), 209–218.PubMed

Minoshima, S., Foster, N. L., Sima, A. A., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001). Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology, 50(3), 358–365.PubMed

Mondon, K., Gochard, A., Marque, A., Armand, A., Beauchamp, D., Prunier, C., et al. (2007). Visual recognition memory differentiates dementia with Lewy bodies and Parkinson’s disease dementia. Journal of Neurology, Neurosurgery and Psychiatry, 78(7), 738–741.

Mori, E., Shimomura, T., Fujimori, M., Hirono, N., Imamura, T., Hashimoto, M., et al. (2000). Visuoperceptual impairment in dementia with Lewy bodies. Archives of Neurology, 57(4), 489–493.PubMed

Morris, J. C. (2006). Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Archives of Neurology, 63(1), 15–16.PubMed

Mosimann, U. P., Mather, G., Wesnes, K. A., O’Brien, J. T., Burn, D. J., & McKeith, I. G. (2004). Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology, 63(11), 2091–2096.PubMed

Muslimovic, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239–1245.PubMed

Muslimovic, D., Schmand, B., Speelman, J. D., & De Haan, R. J. (2007). Course of cognitive decline in Parkinson’s disease: A meta-analysis. Journal of the International Neuropsychological Society, 13(6), 920–932.PubMed

Noe, E., Marder, K., Bell, K. L., Jacobs, D. M., Manly, J. J., & Stern, Y. (2004). Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia. Movement Disorders, 19(1), 60–67.PubMed

Okazaki, H., Lipkin, L. E., & Aronson, S. M. (1961). Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. Journal of Neuropathology and Experimental Neurology, 20, 237–244.PubMed

Paolo, A. M., Axelrod, B. N., Tröster, A. I., Blackwell, K. T., & Koller, W. C. (1996). Utility of a Wisconsin Card Sorting Test short form in persons with Alzheimer’s and Parkinson’s disease. Journal of Clinical and Experimental Neuropsychology, 18(6), 892–897.PubMed

Paolo, A. M., Tröster, A. I., Glatt, S. L., Hubble, J. P., & Koller, W. C. (1995). Differentiation of the dementias of Alzheimer’s and Parkinson’s disease with the Dementia Rating Scale. Journal of Geriatric Psychiatry and Neurology, 8(3), 184–188.PubMed

Perriol, M. P., Dujardin, K., Derambure, P., Marcq, A., Bourriez, J. L., Laureau, E., et al. (2005). Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson’s disease dementia and Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 76(1), 106–108.

Perry, R. H., Irving, D., Blessed, G., Fairbairn, A., & Perry, E. K. (1990). Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences, 95(2), 119–139.PubMed

Perry, E. K., & Perry, R. H. (1995). Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition, 28(3), 240–258.PubMed

Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194.PubMed

Petersen, R. C., & O’Brien, J. (2006). Mild cognitive impairment should be considered for DSM-V. Journal of Geriatric Psychiatry and Neurology, 19(3), 147–154.PubMed

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56(3), 303–308.PubMed

Piccirilli, M., D’Alessandro, P., Finali, G., Piccinin, G. L., & Agostini, L. (1989). Frontal lobe dysfunction in Parkinson’s disease: prognostic value for dementia? European Neurology, 29(2), 71–76.PubMed

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 276(5321), 2045–2047.PubMed

Reid, W. G., Hely, M. A., Morris, J. G., Broe, G. A., Adena, M., Sullivan, D. J., et al. (1996). A longitudinal study of Parkinson’s disease: clinical and neuropsychological correlates of dementia. Journal of Clinical Neuroscience, 3, 327–333.PubMed

Robertson, I. H., Ward, T., Ridgeway, V., & Nimmo-Smith, I. (1996). The structure of normal human attention: The Test of Everyday Attention. Journal of the International Neuropsychological Society, 2(6), 525–534.PubMedCrossRef

Sahgal, A., Galloway, P. H., McKeith, I. G., Lloyd, S., Cook, J. H., Ferrier, I. N., et al. (1992). Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Archives of Neurology, 49(10), 1043–1046.PubMed

Salmon, D. P., Galasko, D., Hansen, L. A., Masliah, E., Butters, N., Thal, L. J., et al. (1996). Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition, 31(2), 148–165.PubMed

Schiller, F. (2000). Fritz Lewy and his bodies. Journal of the History of the Neurosciences, 9, 148–151.PubMed

Shimomura, T., Mori, E., Yamashita, H., Imamura, T., Hirono, N., Hashimoto, M., et al. (1998). Cognitive loss in dementia with Lewy and Alzheimer disease. Archives of Neurology, 55(12), 1547–1552.PubMed

Simard, M., van Reekum, R., & Cohen, T. (2000). A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. Journal of Neuropsychiatry and Clinical Neurosciences, 12(4), 425–450.PubMed

Simard, M., van Reekum, R., & Myran, D. (2003). Visuospatial impairment in dementia with Lewy bodies and Alzheimer’s disease: a process analysis approach. International Journal of Geriatric Psychiatry, 18(5), 387–391.PubMed

Simard, M., van Reekum, R., Myran, D., Panisset, M., Cohen, T., Freedman, M., et al. (2002). Differential memory impairment in dementia with Lewy bodies and Alzheimer’s disease. Brain and Cognition, 49(2), 244–249.PubMed

Tam, C. W., Burton, E. J., McKeith, I. G., Burn, D. J., & O’Brien, J. T. (2005). Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology, 64(5), 861–865.PubMed

Tiraboschi, P., Hansen, L. A., Alford, M., Merdes, A., Masliah, E., Thal, L. J., et al. (2002). Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry, 59(10), 946–951.PubMed

Tiraboschi, P., Salmon, D. P., Hansen, L. A., Hofstetter, R. C., Thal, L. J., & Corey-Bloom, J. (2006). What best differentiates Lewy body from Alzheimer’s disease in early-stage dementia? Brain, 129(Pt 3), 729–735.PubMed

Tolosa, E., Compta, Y., & Gaig, C. (2007). The premotor phase of Parkinson’s disease. Parkinsonism and Related Disorders, 13, S2–S7.PubMed

Tomer, R., Aharon-Peretz, J., & Tsitrinbaum, Z. (2007). Dopamine asymmetry interacts with medication to affect cognition in Parkinson’s disease. Neuropsychologia, 45(2), 357–367.PubMed

Tröster, A. I., & Fields, J. A. (2008). Parkinson’s disease, progressive supranuclear palsy, corticobasal degeneration and related disorders of the frontostriatal system. In J. E. Morgan & J. H. Ricker (Eds.), Textbook of Clinical Neuropsychology (pp. 536–577). New York: Psychology Press.

Tröster, A. I., Fields, J. A., Paolo, A. M., Pahwa, R., & Koller, W. C. (1996). Visual confrontation naming in Alzheimer’s disease and Parkinson’s disease with dementia [abstract]. Neurology, 46(Suppl), A292–293.

Tröster, A. I., Fields, J. A., Testa, J. A., Paul, R. H., Blanco, C. R., Hames, K. A., et al. (1998). Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks. Neuropsychologia, 36(4), 295–304.PubMed

Tröster, A. I., & Woods, S. P. (2005). Neuropsychology of Parkinson’s disease and its dementias. In S. Bush, & T. Martin (Eds.) Geriatric Neuropsychology: Practice essentials (pp. 243–300). New York: Taylor & Francis.

Tröster, A. I., & Woods, S. P. (2007). Neuropsychological Aspects. In R. Pahwa, & K. E. Lyons (Eds.) Handbook of Parkinson’s disease (4th Ed., pp. 109–131). New York: Informa.

Tröster, A. I., Stalp, L. D., Paolo, A. M., Fields, J. A., & Koller, W. C. (1995). Neuropsychological impairment in Parkinson’s disease with and without depression. Archives of Neurology, 52, 1164–1169.PubMed

Tröster, A. I., Woods, S. P., & Morgan, E. E. (2007). Assessing cognitive change in Parkinson’s disease: development of practice effect-corrected reliable change indices. Archives of Clinical Neuropsychology, 22(6), 711–718.PubMed

Troyer, A. K., Moscovitch, M., Winocur, G., Leach, L., & Freedman, M. (1998). Clustering and switching on verbal fluency tests in Alzheimer’s and Parkinson’s disease. Journal of the International Neuropsychological Society, 4(2), 137–143.PubMed

Vendette, M., Gagnon, J. F., Decary, A., Massicotte-Marquez, J., Postuma, R. B., Doyon, J., et al. (2007). REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology, 69(19), 1843–1849.PubMed

Walker, M. P., Ayre, G. A., Perry, E. K., Wesnes, K., McKeith, I. G., Tovee, M., et al. (2000). Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 11(6), 327–335.PubMed

Walker, Z., Allen, R. L., Shergill, S., & Katona, C. L. (1997). Neuropsychological performance in Lewy body dementia and Alzheimer’s disease. British Journal of Psychiatry, 170, 156–158.PubMed

Welsh-Bohmer, K. A., & Warren, L. H. (2006). Neurodegenerative dementias. In D. K. Attix, & K. A. Welsh-Bohmer (Eds.) Geriatric neuropsychology: Assessment and intervention (pp. 56–88). New York: Guilford.

Williams-Gray, C. H., Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain, 130(Pt 7), 1787–1798.PubMed

Wolters, E., & Braak, H. (2006). Parkinson’s disease: premotor clinico-pathological correlations. Journal of Neural Transmission. Supplementum, 70, 309–319.PubMed

Woods, S. P., & Tröster, A. I. (2003). Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease. Journal of the International Neuropsychological Society, 9, 17–24.PubMed

Zaccai, J., McCracken, C., & Brayne, C. (2005). A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age and Ageing, 34(6), 561–566.PubMed

Title: Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers
Author: Alexander I. Tröster
Publication date: 01-03-2008
Publisher: Springer US
Published in: Neuropsychology Review / Issue 1/2008
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-008-9055-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2008

Defining “Prodromal” Alzheimer’s Disease, Frontotemporal Dementia, and Lewy Body Dementia: Are we There Yet?

Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease

MNESIS: Towards the Integration of Current Multisystem Models of Memory

The Early Neuropsychological and Behavioral Characteristics of Frontotemporal Dementia

Errorless Learning in the Rehabilitation of Memory Impairment: A Critical Review

Effects of Temporal Lobe Lesions on Retrograde Memory: A Critical Review